Background and Purpose-We tested the hypothesis that activation of phosphatidylinositol (PI) 3-kinase is involved in dilator responses of the basilar artery to acetylcholine in vivo. Methods-Responses of the basilar artery were measured by the cranial window technique in anesthetized rats. To examine the role of PI 3-kinase in acetylcholine-induced calcium signaling, we measured intracellular free calcium concentration ([Ca
ndothelium-derived relaxing factor, which has been identified as nitric oxide (NO) or its related compound, appears to play a major role in regulation of cerebrovascular tone. 1 It is reported that activation of endothelial nitric oxide synthase (eNOS) by various agonists, including acetylcholine and bradykinin, is mediated primarily by elevation in intracellular free calcium concentration ([Ca 2ϩ ] i ). [2] [3] [4] On the other hand, several stimuli, such as insulin and shear stress, activate NO production in a Ca 2ϩ -independent manner. [5] [6] [7] [8] [9] Thus, both Ca 2ϩ -dependent and -independent mechanisms may be involved in agonist-induced NO production of the endothelial cells (EC).
Phosphatidylinositol (PI) 3-kinase is a novel lipid kinase that phosphorylates the D-3 position of the inositol ring of inositol phospholipids and appears to play an important role in cell growth and oncogenesis. 10 -17 Very recently, it was reported that stimuli promoting NO release independent of elevation in [Ca 2ϩ ] i , such as vascular endothelial growth
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factor (VEGF) and shear stress, activate PI 3-kinase and thereby increase the activity of eNOS through activation of protein kinase B (Akt). 18, 19 Thus, activation of PI 3-kinase plays a major role in NO production in response to these stimuli. It is still not known, however, whether the PI 3-kinase/Akt pathway is also involved in NO-dependent dilator responses of the cerebral blood vessels, especially in vivo.
We have shown recently that activation of tyrosine kinase is involved in acetylcholine-induced dilatation of rat basilar artery in vivo. 20 Because the activity of PI 3-kinase appears to be closely related to protein tyrosine kinase, 10 it may be possible that activation of PI 3-kinase is also involved in dilatation of the basilar artery in response to acetylcholine, whose receptor belongs to G protein-coupled receptors. 21 Thus, the first goal of the present study was to test the hypothesis that acetylcholine-induced dilatation of the basilar artery is mediated by activation of PI 3-kinase in vivo.
It is reported that activation of tyrosine kinase is involved in agonist-induced changes in [Ca 2ϩ ] i of cultured umbilical vein EC. [22] [23] [24] On the other hand, the mechanism through the PI 3-kinase/Akt pathway may not be involved in agonistinduced calcium signaling, as previously discussed. Thus, it is important to determine whether activation of tyrosine kinase and PI 3-kinase is related to acetylcholine-induced changes in [Ca 2ϩ ] i . The second goal of the present study was to investigate the role of both these protein kinases in acetylcholineinduced calcium signaling of basilar arterial EC.
Materials and Methods
This study was performed under the control of the guidelines for animal experiments in the Graduate School of Medical Sciences, Kyushu University.
Cranial Window
Experiments were performed on male Sprague-Dawley rats (meanϮSEM weight, 354Ϯ8 g; age, 2 to 4 months; nϭ23), anesthetized with amobarbital (50 mg/kg IP). Catheters were placed in bilateral femoral arteries to measure systemic blood pressure and to obtain arterial blood. The right femoral vein was cannulated for infusion of supplemental anesthetic (20 to 25 mg/kg per hour). The trachea was cannulated, and the animals were mechanically ventilated with room air and supplemental oxygen. Arterial blood gas monitored during the experiments had a pH of 7.42Ϯ0.00, a PCO 2 of 40Ϯ1 mm Hg, and a PO 2 of 135Ϯ6 mm Hg. Skeletal muscle paralysis was produced with d-tubocurarine chloride (2 mg/kg IV). Depth of anesthesia was evaluated by applying pressure to a paw or the tail and observing changes in heart rate or blood pressure. Additional anesthetic was administered when such changes occurred. Body temperature was maintained with a heating pad (36.6°C). A craniotomy was prepared over the ventral brain stem as previously described in detail. [25] [26] [27] In brief, after a part of the dura was opened, the cranial window was suffused with artificial cerebrospinal fluid (aCSF) (temperatureϭ36.2°C; ionic composition [in mmol/L]: 132 NaCl, 2.95 KCl, 1.71 CaCl 2 , 0.65 MgCl 2 , 24.6 NaHCO 3 , 3.69 D-glucose) that was bubbled continuously with appropriate gases. aCSF sampled from the cranial window had a pH of 7.40Ϯ0.01, a PCO 2 of 38Ϯ1 mm Hg, and a PO 2 of 117Ϯ3 mm Hg. After the preparation was completed, the window was suffused with the aCSF for at least 1 hour before the experiment.
Diameters of the blood vessels were measured with a microscope equipped with a television camera coupled to an autowidth analyzer (C3161, Hamamatsu Photonics). We examined responses of the basilar artery to topical application of acetylcholine (10 Ϫ6 , 10
, and 10 Ϫ5 mol/L), bradykinin (10 Ϫ7 and 10 Ϫ6 mol/L), and an NO donor, sodium nitroprusside (10
Ϫ8
, 10 Ϫ7 , and 10 Ϫ6 mol/L). We decided the dose of these vasodilators according to prior reports in which cranial window technique was used to produce effective dilator responses of the basilar artery in Sprague-Dawley rats. 20, 28, 29 The vasodilators were mixed in aCSF and suffused over the craniotomy for 5 minutes. Diameters of the basilar artery were measured immediately before and during the last minute of application of each agonist. After application of a specific agonist, vessel diameters returned to the baseline level within a few minutes before subsequent application of an agonist. The application sequence of agonists was randomized. We used 2 different inhibitors of PI 3-kinase, wortmannin (10 (data not shown). Thus, vasodilator responses to these agonists were mediated primarily by NO. 26 Wortmannin was dissolved in dimethyl sulfoxide and diluted with aCSF. The final concentration of dimethyl sulfoxide was Ͻ0.1%, and dimethyl sulfoxide at that concentration did not cause any significant change in diameter of the basilar artery (data not shown). Acetylcholine, sodium nitroprusside, LY294002, and bradykinin were dissolved in aCSF. Topical application of these agents did not cause any changes in systemic arterial pressure (data not shown).
Measurement of [Ca 2؉ ] i
EC were collected from the basilar artery of male Sprague-Dawley rats aged 4 to 6 weeks. After the rats were anesthetized with diethyl ether, they were decapitated, and the basilar artery was quickly removed under sterile conditions. The arterial segments were carefully cleaned of connective tissue, cut in small fragments, and placed in culture dishes coated with collagen type 1. The growth medium (Dulbecco's modified Eagle's medium) was supplemented with 10% fetal bovine serum, 1% penicillin-streptomycin solution, 5 g ⅐ mL
Ϫ1
EC growth supplements, and 10 U/mL heparin. The dishes were incubated at 37°C in a humidified atmosphere of 95% air and 5% CO 2 . After a few days, colonies of EC with cobblestone pattern, which were typical for EC, proliferated from the basilar arterial segments. After the arterial segment was removed, the primary EC colonies were gently scraped off and subcultured in other dishes. mol/L), a tyrosine kinase inhibitor, for 20 minutes before application of acetylcholine. In the Ca 2ϩ -free buffer, extracellular Ca 2ϩ was omitted and 1 mmol/L EGTA was added. Acetylcholine stock solution (10 L) was added to the dish quietly (final concentration 10 Ϫ5 mol/L), and the changes in the fluorescence ratio were measured approximately every 3 seconds for 3 minutes. We performed 8 independent experiments in each protocol. All experiments were performed at room temperature.
Materials
Acetylcholine, sodium nitroprusside, wortmannin, LY294002, and genistein were all from Sigma. Bradykinin was from Wako. Cell culture medium was also purchased from Sigma, except for fetal bovine serum, which was from GIBCO. Collagen type 1, which was used to coat coverslip-bottomed culture dishes, was from Iwaki. Indo 1-AM was from Molecular Probes or Dojin. 
Statistical Analysis

Results
Effects of PI 3-Kinase Inhibitors on Vasodilatation
Under control conditions, diameter of the basilar artery was 241Ϯ3 m. Topical application of acetylcholine (10 Ϫ6
Ϫ5 mol/L) produced dilatation of the basilar artery in a concentration-related manner (8Ϯ1%, 14Ϯ2%, and 24Ϯ3%, respectively; Figure 1a) . Acetylcholine-induced vasodilatation was reproducible, since there was no significant attenuation of the response during repeated application of acetylcholine (data not shown). Wortmannin (10 Ϫ8 mol/L) had no effect on the baseline diameter of the basilar artery but inhibited dilatation of the basilar artery in response to acetylcholine (Figure 1a) , with an IC 50 value of approximately 1.9ϫ10
Ϫ9 mol/L (Figure 1b ). LY294002 (10 Ϫ5 mol/L) did not affect the baseline diameter of the basilar artery but inhibited acetylcholine-induced vasodilatation significantly (Figure 2a) .
Application of sodium nitroprusside (10
Ϫ8
, 10
Ϫ7
, and 10
Ϫ6
mol/L) also produced dilatation of the basilar artery in a concentration-related manner (9Ϯ1%, 42Ϯ5%, and 67Ϯ4%, respectively; Figure 1c ). Neither wortmannin (10 Ϫ8 mol/L) nor LY294002 (10 Ϫ5 mol/L) affected vasodilatation produced by sodium nitroprusside (Figures 1c and 2b) .
Application of bradykinin (10 Ϫ7 and 10 Ϫ6 mol/L) dilated the basilar artery in a concentration-related manner (3.7Ϯ0.7% and 13.4Ϯ4.3%, respectively; Figure 3 ). Wortmannin (10 Ϫ8 mol/L) also attenuated bradykinin-induced dilatation of the basilar artery significantly (Figure 3 ). 
Effects of Tyrosine
Discussion
There are 2 major new findings in the present study. First, acetylcholine-induced dilatation of rat basilar artery may be mediated, at least in part, by activation of PI 3-kinase in vivo. Because acetylcholine-induced dilatation of the artery appears to be mediated primarily by NO and activation of the kinase does not contribute to vasodilatation produced by an NO donor, activation of PI 3-kinase may have an important role in acetylcholine-induced NO production in the basilar arterial EC. The present study is the first thus far to show the role of PI 3-kinase in NO-dependent dilator responses of the cerebral artery in vivo. Second, activation of tyrosine kinase may contribute to acetylcholine-induced Ca 2ϩ influx to the EC, but the activity of PI 3-kinase may not have any significant influence on acetylcholine-induced [Ca 2ϩ ] i changes of the EC. Thus, activation of PI 3-kinase may have a role in acetylcholine-induced NO production of the basilar arterial EC in a calcium-independent manner. 
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Role of PI 3-Kinase in Acetylcholine-Induced Vasodilatation
Several groups have shown recently that NO production of EC stimulated by VEGF, insulin, and shear stress is mediated by activation of PI 3-kinase. [5] [6] [7] [8] [9] 35 Because all these stimuli do not increase [Ca 2ϩ ] i , PI 3-kinase activate NO production in a calcium-independent manner. We have shown recently that dilatation of the basilar artery in response to acetylcholine, an agonist of G protein-coupled receptor, is mediated, at least in part, by activation of tyrosine kinase in vivo. 20 Because PI 3-kinase has a Src homology 2 domain in its regulatory subunit, which interacts with phosphotyrosine and is closely related to the activity of tyrosine kinase, it may be possible that PI 3-kinase is also involved in acetylcholine-induced dilator responses of the basilar artery. There are no data, however, regarding the role of PI 3-kinase in dilator responses of the cerebral blood vessels to agonists of G protein-coupled receptors. In the present study 2 different inhibitors of PI 3-kinase, wortmannin and LY294002, produced marked inhibition of acetylcholine-induced dilatation of the artery in vivo. Wortmannin also attenuated vasodilatation induced by bradykinin, another G protein-dependent agonist. 36 Thus, PI 3-kinase is functionally active in the basilar artery in vivo and may play an important role in vasodilator responses to acetylcholine and bradykinin. Neither of these 2 inhibitors affected dilator responses of the basilar artery to an NO donor, sodium nitroprusside. Thus, PI 3-kinase may not be involved in NO actions on vascular muscle but may contribute to NO production in the EC through activation of G protein-coupled receptors.
The concern of this study may be specificity of the inhibitors of PI 3-kinase. [37] [38] [39] In this study wortmannin inhibited vasodilator responses to acetylcholine in a concentration-dependent manner, and the IC 50 (1.9ϫ10 Ϫ9 mol/L) was similar to those reported in recent studies (1.8 to 4.0ϫ10 Ϫ9 mol/L). 39 Much higher concentrations of wortmannin are reported to be necessary for the inhibition of other kinases. 37, 39 LY294002, another inhibitor of PI 3-kinase, is a competitive inhibitor for the ATP binding site of PI 3-kinase and has no inhibitory effects on phosphatidylinositol 4-kinase and other ATP-requiring protein kinases and lipid kinases. 40 Thus, the inhibitory action of the inhibitors on acetylcholineinduced vasodilatation is likely to be specific for PI 3-kinase. The findings that these 2 inhibitors did not affect vasodilatation produced by sodium nitroprusside may further support our interpretation.
Topical application of inhibitors of NO synthase (NOS) produces constriction of rat basilar artery in vivo. 26, 41 Thus, synthesis of NO influences the resting tone of the basilar artery. In the present study neither wortmannin nor LY294002 affected baseline diameter of the basilar artery. These findings may suggest that PI 3-kinase is not involved in basal production of NO in the basilar artery in vivo. The signal transduction pathway of basal production of NO may be different from that of agonist-induced NO production in the EC, although the precise molecular mechanisms are unclear. However, we cannot exclude the possibility that some compensatory mechanisms have counteracted the inhibitory actions of wortmannin and LY294002 on vasodilator responses under control conditions in vivo. For example, it is possible that activation of PI 3-kinase may also be involved in vasoconstrictor responses as well as vasodilator responses. Saward and Zahradka, 42 using immunostaining, have shown the existence of PI 3-kinase in vascular muscle. Thus, inhibition of PI 3-kinase may have attenuated constrictor responses as well as dilator responses of the basilar artery and thereby masked inhibitory effects of PI 3-kinase inhibitors on vasodilator responses under control conditions. We have shown recently that both acetylcholine-induced dilatation 20 and serotonin-induced constriction 43 of the basilar artery were mediated by activation of tyrosine kinase and that the inhibitors of tyrosine kinase did not affect the baseline diameter of the basilar artery. Because the activity of PI 3-kinase appears to be closely related to tyrosine kinase, 10 it may be possible that the inhibitors of PI 3-kinase also have actions on the basilar artery similar to those of the tyrosine kinase inhibitors.
Calcium Signaling and PI 3-Kinase
Several groups have reported that changes in [Ca 2ϩ ] i of cultured vascular EC are dependent on activation of tyrosine kinase. [22] [23] [24] In the studies several different inhibitors of tyrosine kinase attenuated agonist-induced Ca 2ϩ influx but not Ca 2ϩ release from intracellular store sites in cultured EC. In the present study we have also found that genistein inhibited the sustained increase in [Ca 2ϩ ] i of cultured basilar arterial EC, which reflects acetylcholine-induced Ca 2ϩ influx. These results suggest that activation of tyrosine kinase may cause Ca 2ϩ influx and thereby activate NOS in the basilar arterial EC.
On the other hand, wortmannin did not affect acetylcholine-induced [Ca 2ϩ ] i changes in the basilar arterial EC. Thus, activation of PI 3-kinase may not be involved in calcium signaling of the basilar arterial EC. PI 3-kinase may play an important role in acetylcholine-induced NO production of the basilar artery in a calcium-independent manner. Recent evidence has shown that G protein-coupled receptorindependent stimuli, such as VEGF and shear stress, induce activation of the PI 3-kinase/Akt pathway and thereby directly stimulate eNOS, which is independent of elevation in [Ca 2ϩ ] i . 18, 19 The investigators discussed the possibility that Akt enhances the sensitivity of eNOS to calcium-calmodulin complex. Thus, it may be possible that acetylcholine activates PI 3-kinase, concomitant with the increase in [Ca 2ϩ ] i , and thereby stimulates eNOS in a synergistic manner.
There are several possible mechanisms by which acetylcholine activates PI 3-kinase. Acetylcholine receptors belong to a G protein-coupled receptor family, and G proteins are reported to activate PI 3-kinase directly in some cellular types. 21, 44 Thus, it is possible that the ␤␥ subunits of the G protein coupled to acetylcholine receptors directly activate both tyrosine kinase and PI 3-kinase. Another possibility is that some phosphotyrosine produced by activation of tyrosine kinase interacts with Src homology 2 domain of PI 3-kinase and thereby activates PI 3-kinase in the EC.
In summary, activation of PI 3-kinase as well as tyrosine kinase may play an important role in acetylcholine-induced NO production of the basilar arterial EC and thereby contribute to acetylcholine-induced dilator responses of the artery in vivo. Tyrosine kinase may account for acetylcholine-induced Ca 2ϩ influx to the EC, and PI 3-kinase may activate eNOS in a calcium-independent manner. 
Editorial Comment
Studies from both experimental animals and humans have shown that NO plays a major role in regulation of cerebral vascular tone under basal conditions and in response to receptor-mediated agonists, including acetylcholine. [1] [2] [3] The goal of the present study was to better define the signal transduction pathway that mediates responses of the basilar artery to acetylcholine and bradykinin. Relaxation of this artery in response to these agonists is known to be endothelium dependent and mediated by the endothelial isoform of NOS (CC). 1, 2 The results of the present study suggest that dilatation of the basilar artery in response to acetylcholine and bradykinin is mediated, at least in part, by activation of PI 3-kinase. This conclusion is based on the finding that 2 different pharmacological inhibitors of PI 3-kinase selectively attenuated responses to these agonists. Because responses to an NO donor were not affected by the same inhibitors, the investigators suggest that PI 3-kinase activity was influencing production of NO. Additional studies with basilar artery endothelium and calcium imaging in vitro suggest that PI 3-kinase does not influence acetylcholine-induced calcium fluxes, raising the possibility that PI 3-kinase influences production of NO via a calcium-independent mechanism.
Another interesting finding from the study relates to the observation that inhibitors of PI 3-kinase attenuated responses to acetylcholine but had no effect on baseline diameter, even though production of NO appears to be relatively high in the basilar artery under basal conditions. 1 These findings raise the possibility that basal versus agonistinduced production of NO may be regulated in part through different mechanisms. 
